Our study demonstrates that glucagon, through its interaction with GCGR and/or GLP-1R, plays a pivotal role in orchestrating metabolic and adaptive responses in both tumour and normal endocrine cells, particularly under conditions of glucose deprivation. This evidence concerns the gene GCG and neoplasm.